-1.png)
Expanding NPI Visibility & Targeted Engagement in Rare Disease via Lab Data
Executive Summary In complex clinical populations like rare disease, lab data serves as a vital...
Hereditary Angioedema: Unlocking Earlier Diagnosis
Leveraging Quest Diagnostics Data and Prognos Health Algorithms
AI Is Making Healthcare Data Smarter. It’s Also Making Clinical Signal More Valuable.
One of the more telling healthcare AI developments of 2026 was not about replacing diagnostics with...
The Biological Window in Alzheimer’s Disease: Real-World Lab Data for Commercial Execution
For real-world data (RWD) and commercial teams navigating the complex landscape of early-stage...
.png)
Precision Targeting in Rare Disease: Why Lab Data is the "Early Warning System" Pharma Needs
We are living in an era of unprecedented rare disease advocacy. Medical parents and patient groups...
The Data Quality Illusion: Why Aggregated EHR Feeds Often Fail
In the life sciences industry, "lab data" is often treated as a commodity. The assumption is that a...
Tracking the Shift: Real-World Adoption of Emerging IHC Markers in Early 2026
Moving beyond the "hype" to seeing actual testing adoption on the ground.
The New Precision Oncology Battleground: Tracking FOLR1, CLDN18.2, and cMET
As Antibody-Drug Conjugates (ADCs) reshape the therapeutic landscape, commercial success depends on...
Shining a Light on Colorectal Cancer Awareness Month
Shining a Light on Colorectal Cancer Awareness Month March is Colorectal Cancer Awareness Month, a...
Keeping the Focus on Kidney Health: Beyond World Kidney Day and the Nuances of CKD
World Kidney Day, observed yesterday on March 13, served as a powerful reminder of the critical...